Alithya Reports Q3 Net Earnings Amidst Significant Goodwill Impairment and Ongoing Internal Control Weakness
summarizeSummary
Alithya Group reported positive net earnings for Q3 2025, but a substantial goodwill and intangible asset impairment of $38.0 million for the nine-month period led to a significant year-to-date net loss. The company also disclosed an ongoing material weakness in its internal controls over financial reporting.
check_boxKey Events
-
Significant Goodwill and Intangible Impairment
The company recognized a $38.0 million impairment loss on goodwill and intangibles for the nine months ended December 31, 2025, primarily affecting its Canada and Industry Solutions cash-generating units due to unachieved profitability targets.
-
Ongoing Material Weakness in Internal Controls
Management identified an ongoing material weakness in internal control over financial reporting related to revenue processes for fixed-fee and time and material arrangements, a deficiency first reported in March 2025.
-
Mixed Revenue Performance
Q3 2025 revenues decreased slightly by 0.5% to $115.2 million, while year-to-date revenues increased by 4.4% to $363.6 million, driven by U.S. growth (including the eVerge acquisition) but offset by a decline in Canada.
-
Year-to-Date Net Loss Worsens
Despite Q3 2025 net earnings of $0.7 million, the significant impairment led to a year-to-date net loss of $30.1 million, a substantial increase from the $6.7 million loss in the prior year period.
auto_awesomeAnalysis
Alithya Group's latest 6-K filing reveals a mixed financial picture, with Q3 2025 net earnings of $0.7 million, a notable improvement from a loss in the prior year. However, the nine-month period was severely impacted by a $38.0 million impairment of goodwill and intangible assets, primarily in its Canada and Industry Solutions segments, indicating underperformance in these areas. This impairment, representing a substantial portion of the company's market capitalization, resulted in a significant year-to-date net loss of $30.1 million. Furthermore, the company continues to report a material weakness in its internal controls over financial reporting related to revenue processes, a critical governance concern that has been ongoing since March 2025. While adjusted EBITDA and operating cash flow showed some resilience, particularly year-to-date, the declining backlog and flat Q3 revenues, coupled with the large impairment and control issues, present a challenging outlook. The eVerge acquisition contributed to U.S. revenue growth, but overall new business momentum appears to be slowing.
At the time of this filing, ALYAF was trading at $1.17 on OTC in the Technology sector, with a market capitalization of approximately $116.5M. The 52-week trading range was $0.95 to $1.97. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.